Feed / PNTG

The Pennant Group, Inc.

PNTG

Healthcare · 39.33 -0.7% today

Isolated · not yet confirmedMarket checked 10 Sept, 15:55 GMT-4

Market read

The Pennant Group, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.

Company-0.7% todayVolume comparison unavailable
Market group0 of 1 activeHome Health & Hospice · unavailable
Disclosed network0 of 1 confirmingNo filing-linked name is confirming now
What would change this read
  • PNTG's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if PNTG's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Medical Care Facilities

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 1 directly disclosed connection is confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • PNTG's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations319
Usable filing statements90
Verified relationships1
Evidence supporting the case
  • Latest annual revenue changed +36.3% year over year.
Evidence challenging the case
  • Diluted shares increased 10.4% in the latest annual period.
Questions before a position
  • P/E is 111% above the available filing-peer median; determine whether growth and quality justify the difference.
  • EV/sales is 23% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 10, 2026

39.33
6m+16.7%12m+60.6%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$439.7M+12.5%$0.09+1.4%
2022-12-31$473.2M+7.6%$0.22-1.6%
2023-12-31$544.9M+15.1%$0.44+0.1%
2024-12-31$695.2M+27.6%$0.70+6.0%
2025-12-31$947.7M+36.3%$0.84+10.4%

What management says matters

Persistent and emerging business drivers

Credit and interest ratesmixed · 4 filings
We calculate Consolidated EBITDA as net income, adjusted for net income attributable to noncontrolling interest, before (a) interest expense (b) provision for income taxes and (c) depreciation and amortization.
10-Q · May 6, 2026
Restructuring and cost reductionsmixed · 3 filings
We develop information about the size of the ultimate claims based on historical experience, current industry information, and actuarial analysis; • Revenue recognition - The amounts owed by private pay individuals for services and estimate of variable consid…
10-Q · May 6, 2026
Labor availability and costspositive · 1 filings
Staffing challenges increased during the pandemic and have persisted due to health care worker burnout, vaccine mandates, and wage inflation, increasing the competition for qualified staff and cost of retaining personnel, and continue to affect our operations.
10-K · Feb 26, 2026
Macroeconomic conditionspositive · 1 filings
Staffing challenges increased during the pandemic and have persisted due to health care worker burnout, vaccine mandates, and wage inflation, increasing the competition for qualified staff and cost of retaining personnel, and continue to affect our operations.
10-K · Feb 26, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 1.5× · EV/sales 1.6×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

39.33-0.7% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for PNTG. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for PNTG. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind PNTG

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

UNHUnitedHealth Group IncorporatedinvesteeFeb 26, 2026

The changes to the peer group were necessitated by the acquisition of AMED by UnitedHealth Group Incorporated (“UnitedHealth”) and the spin-off of EHAB from EHC.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

PNTG is currently a Leader in the organic co-movement group Home Health & Hospice. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for PNTG; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.